Literature DB >> 6634703

Calcium channel blockers: potential antimetastatic agents.

K V Honn, J M Onoda, C A Diglio, B F Sloane.   

Abstract

The calcium channel blocker nifedipine (Bay A 1040) was examined for its effects on tumor cell-platelet interactions. In vitro, nifedipine inhibited tumor cell-induced platelet aggregation and platelet enhanced tumor cell adhesion to confluent endothelial cell monolayers and in vivo nifedipine inhibited pulmonary tumor colony formation ("experimental metastasis") by intravenously injected tumor cells. This evidence suggests that calcium channel blockers may be a new class of antimetastatic agents.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6634703     DOI: 10.3181/00379727-174-1-rc2

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  6 in total

Review 1.  Calcium antagonists and cancer. Is there really a link?

Authors:  L G Howes; C T Edwards
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

2.  Action of Iron Nitrosyl Complexes, NO Donors, on the Activity of Sarcoplasmic Reticulum Ca2+-ATPase and Cyclic Guanosine Monophosphate Phosphodiesterase.

Authors:  L V Tat'yanenko; N A Sanina; O V Dobrokhotova; A I Kotelnikov; N S Goryachev; I I Pihteleva; G I Kozub; T A Kondrateva
Journal:  Dokl Biochem Biophys       Date:  2018-03-14       Impact factor: 0.788

Review 3.  Shaping future strategies for the pharmacological control of tumor cell metastases.

Authors:  R G Greig; D L Trainer
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

4.  Interaction of antiestrogens with binding sites for muscarinic cholinergic drugs and calcium channel blockers in cell membranes.

Authors:  S Batra
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

5.  Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.

Authors:  J Timar; H Chopra; X Rong; J S Hatfield; S E Fligiel; J M Onoda; J D Taylor; K V Honn
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  Inhibition of spontaneous and experimental tumor metastasis by the calcium antagonist verapamil.

Authors:  T Tsuruo; H Iida; F Makishima; T Yamori; H Kawabata; S Tsukagoshi; Y Sakurai
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.